Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kazia Therapeutics Ltd (KZIA)

6.2   0.47 (8.2%) 08-13 16:00
Open: 5.68 Pre. Close: 5.73
High: 6.475 Low: 5.64
Volume: 262,911 Market Cap: 45M
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is headquartered in Sydney, Australia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.476 - 6.501 6.501 - 6.53
Low: 5.579 - 5.603 5.603 - 5.631
Close: 6.152 - 6.193 6.193 - 6.241

Technical analysis

as of: 2020-08-13 4:35:54 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.57     One year: 11.17
Support: Support1: 5.14    Support2: 3.25
Resistance: Resistance1: 8.19    Resistance2: 9.57
Pivot: 4.72
Moving Average: MA(5): 6.00     MA(20): 4.57
MA(100): 3.32     MA(250): 3.57
MACD: MACD(12,26): 0.59     Signal(9): 0.40
Stochastic oscillator: %K(14,3): 47.29     %D(3): 47.89
RSI: RSI(14): 73.66
52-week: High: 9.74  Low: 2.27  Change(%): 160.5
Average Vol(K): 3-Month: 46170  10-Days: 237125

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
KZIA has closed below upper band by 10.4%. Bollinger Bands are 329.2% wider than normal. The large width of the bands suggest high volatility as compared to KZIA's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Thu, 13 Aug 2020
Is it Time to Dump Kazia Therapeutics Ltd (KZIA) Stock After it Is Higher By 42.15% in a Week? - InvestorsObserver

Tue, 11 Aug 2020
Kazia Therapeutics Limited (KZIA) investors to reap big returns again - Marketing Sentinel

Tue, 11 Aug 2020
74 Biggest Movers From Yesterday - Benzinga

Mon, 10 Aug 2020
Could Kazia Therapeutics Limited [KZIA] rocket further after FDA gives RPDD for Cancer Treatment? -

Fri, 07 Aug 2020
Kazia Therapeutics News: Why KZIA Stock Is Rocketing 43% Higher Today - InvestorPlace

Fri, 07 Aug 2020
Should You Buy Kazia Therapeutics Ltd (KZIA) in Biotechnology Industry? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 7
Shares Float (M) 4
% Held by Insiders
% Held by Institutions 3.56
Shares Short (K) 10
Shares Short P. Month (K) 6

Stock Financials

EPS -0.920
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.940
Profit Margin
Operating Margin
Return on Assets (ttm) -25.9
Return on Equity (ttm) -66.1
Qtrly Rev. Growth -18.6
Gross Profit (p.s.) 0.213
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -6.74
PEG Ratio
Price to Book value 2.11
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.